204 related articles for article (PubMed ID: 26280253)
1. Cost-effectiveness analysis of papillary thyroid cancer surveillance.
Wang LY; Roman BR; Migliacci JC; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Cancer; 2015 Dec; 121(23):4132-40. PubMed ID: 26280253
[TBL] [Abstract][Full Text] [Related]
2. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
Garcia A; Palmer BJ; Parks NA; Liu TH
Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer.
Wu JX; Beni CE; Zanocco KA; Sturgeon C; Yeh MW
Thyroid; 2015 Jul; 25(7):797-803. PubMed ID: 25851702
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.
Wang LY; Roman BR; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Surgery; 2016 May; 159(5):1390-5. PubMed ID: 26747227
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
6. Utility of routine ultrasonography follow-up after total thyroidectomy in patients with papillary thyroid carcinoma: a single-center study.
Park HK; Kim DW; Ha TK; Heo YJ; Baek JW; Lee YJ; Cho YJ; Lee DK; Kim DH; Jung SJ; Ahn KJ; Ahn HS; Baek HJ
BMC Med Imaging; 2018 May; 18(1):12. PubMed ID: 29764382
[TBL] [Abstract][Full Text] [Related]
7. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
8. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
9. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Bellantone R; Raffaelli M; De Crea C; Sessa L; Traini E; Princi P; Lombardi CP
World J Surg; 2018 Feb; 42(2):402-408. PubMed ID: 29238849
[TBL] [Abstract][Full Text] [Related]
10. SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
Yang SP; Bach AM; Tuttle RM; Fish SA
Endocr Pract; 2015 Dec; 21(12):1372-9. PubMed ID: 26372300
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
12. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
13. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
14. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
15. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
16. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
18. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
[TBL] [Abstract][Full Text] [Related]
19. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
[TBL] [Abstract][Full Text] [Related]
20. Analysis of postoperative ultrasonography surveillance after total thyroidectomy in patients with papillary thyroid carcinoma: a multicenter study.
Ryoo I; Kim DW; Lee CY; Huh JY; Lee S; Ahn HS; Sung JY
Acta Radiol; 2018 Feb; 59(2):196-203. PubMed ID: 28343399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
